Heterozygote screening for Tay-Sachs disease: past successes and future challenges
- PMID: 9018448
- DOI: 10.1097/00008480-199612000-00014
Heterozygote screening for Tay-Sachs disease: past successes and future challenges
Abstract
Tay-Sachs disease (TSD) is an autosomal recessive, neurodegenerative disorder caused by a deficiency of beta-hexosaminidase A activity. Mass screening for TSD heterozygotes has been routine in the Ashkenazi Jewish population since the early 1970s. Recent advances in the molecular genetics and epidemiology of TSD require a reevaluation of heterozygote screening practices. The use of DNA-based analyses for a panel of common mutations detects about 98% of TSD mutations found in the Ashkenazi Jews and about 50% of TSD mutations found in the general non-Jewish population; enzyme-based analysis has nearly 100% sensitivity for all populations. We recommend 1) that members of several ethnic groups and persons with a family history consistent with TSD be offered testing for TSD heterozygosity and 2) that assays of enzyme activity be used as the primary screening tool, with mutation analysis used as an adjunct tool in certain cases.
Similar articles
-
Rapid nonradioactive tracer method for detecting carriers of the major Ashkenazi Jewish Tay-Sachs disease mutations.Clin Chem. 1992 Nov;38(11):2249-55. Clin Chem. 1992. PMID: 1424119
-
Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network.JAMA. 1993 Nov 17;270(19):2307-15. JAMA. 1993. PMID: 8230592
-
The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.Sao Paulo Med J. 2001 Jul 5;119(4):146-9. doi: 10.1590/s1516-31802001000400007. Sao Paulo Med J. 2001. PMID: 11500789 Free PMC article.
-
Tay-Sachs disease carrier screening: a model for prevention of genetic disease.Genet Test. 1998;2(4):271-92. doi: 10.1089/gte.1998.2.271. Genet Test. 1998. PMID: 10464605 Review.
-
Tay-Sachs disease screening and diagnosis: evolving technologies.DNA Cell Biol. 1993 Oct;12(8):651-65. doi: 10.1089/dna.1993.12.651. DNA Cell Biol. 1993. PMID: 8397824 Review.
Cited by
-
Next-generation DNA sequencing of HEXA: a step in the right direction for carrier screening.Mol Genet Genomic Med. 2013 Nov;1(4):260-8. doi: 10.1002/mgg3.37. Epub 2013 Sep 16. Mol Genet Genomic Med. 2013. PMID: 24498621 Free PMC article.
-
Hexosaminidase assays.Glycoconj J. 2009 Nov;26(8):945-52. doi: 10.1007/s10719-008-9137-5. Glycoconj J. 2009. PMID: 18473163
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous